CONDITION

Atopic Dermatitis in Dogs

A chronic inflammatory skin condition driven by immune hypersensitivity to environmental allergens, causing recurring itch and discomfort.

Why this matters now

Atopic dermatitis typically first manifests in dogs between one and three years of age, though it can appear outside this range. Certain breeds are disproportionately represented, including French Bulldogs, Labrador Retrievers, Golden Retrievers, West Highland White Terriers, Bulldogs, and Shar Peis, suggesting a strong genetic component. The condition reflects an underlying predisposition to mount exaggerated immune responses to environmental allergens such as pollens, dust mites, and mould spores, meaning that the triggers are often unavoidable components of the dog's normal environment.

Atopic dermatitis is typically a lifelong condition, though its severity and pattern may shift over time. Many dogs experience seasonal flares initially, often correlating with pollen seasons, which may gradually evolve into year-round symptoms as the range of allergens the dog reacts to broadens. Secondary infections with bacteria or yeast are common and can amplify the discomfort and skin changes considerably. The skin's barrier function tends to deteriorate over time in affected dogs, creating a cycle where damaged skin allows greater allergen penetration, which triggers further inflammation and more barrier damage.

Signals & patterns

Early signals

Persistent itching and scratching

The hallmark of atopic dermatitis is pruritus (itching) that often begins as seemingly minor scratching, face rubbing, or paw licking. The itching may initially appear seasonal, worsening during spring or autumn when pollen counts are high. Dogs may scratch at their ears, rub their face along furniture or carpet, or lick their paws persistently. The intensity can fluctuate from day to day and may be worse after outdoor activity or in certain environments.

Reddened skin in characteristic locations

Erythema (redness) typically appears in specific areas: the ventral abdomen, axillae (armpits), groin, interdigital spaces (between the toes), inner ear flaps, and periocular regions (around the eyes). These areas tend to have thinner skin and greater exposure to environmental allergens. The distribution pattern is often one of the most useful features in distinguishing atopic dermatitis from other causes of itchy skin.

Recurrent ear inflammation

Otitis externa (ear canal inflammation) is frequently one of the earliest and most persistent features of atopic dermatitis in dogs. Affected ears may appear red, produce excess wax or discharge, and the dog may shake its head or scratch at its ears frequently. In some dogs, ear problems are the most prominent or even the sole initial manifestation of atopic dermatitis, and the connection to an underlying allergic condition may not be recognised for some time.

Paw licking and chewing

Dogs may lick or chew at their paws persistently, sometimes leading to brown staining of the fur (from porphyrin in saliva) between the toes or on the tops of the feet. The interdigital skin may become moist, reddened, and swollen. This behaviour often intensifies after walks or during particular seasons and can be one of the more visible early indicators of an underlying allergic process.

Later signals

Chronic skin thickening and hyperpigmentation

With ongoing inflammation, the skin may undergo lichenification, where it becomes thickened, roughened, and develops an exaggerated texture. Hyperpigmentation (darkening of the skin) often accompanies these chronic changes, particularly in the axillae, groin, and ventral abdomen. These changes reflect the cumulative effect of prolonged inflammation and repeated self-trauma from scratching and licking, and they may not fully resolve even when the inflammation is controlled.

Recurrent bacterial and yeast infections

The compromised skin barrier and altered microbiome in atopic dogs predispose to secondary infections. Bacterial pyoderma (often Staphylococcus pseudintermedius) may present as pustules, crusting, or circular areas of hair loss with surrounding scale. Malassezia yeast overgrowth typically causes a greasy, musty odour, increased wax production in ears, and intensified itching. These infections can become cyclical, resolving with treatment only to recur when antimicrobial therapy is discontinued.

Hair loss and skin excoriation

Persistent self-trauma from scratching, licking, and chewing leads to patchy hair loss (alopecia), skin abrasions, and sometimes open wounds. The pattern of hair loss often follows the distribution of the dog's itching behaviour, with the flanks, legs, and ventral surfaces commonly affected. In severe cases, dogs may develop hot spots (acute moist dermatitis) where intense localised itching leads to a rapidly developing, painful, oozing lesion.

Behavioural impact of chronic itch

Dogs with poorly controlled atopic dermatitis may show signs consistent with chronic discomfort including restlessness, disturbed sleep, irritability, and reduced engagement with normal activities. The constant urge to scratch can disrupt rest and play, and some dogs develop anxiety-like behaviours associated with their skin discomfort. The impact on quality of life can be significant and may affect the dog's temperament and social interactions.

Click to read about the biological mechanisms

How this is usually investigated

Diagnosing atopic dermatitis is largely a clinical process based on history, clinical presentation, and exclusion of other causes of itchy skin. There is no single definitive test that confirms the diagnosis; rather, it is reached through a methodical process of ruling out conditions that can mimic or complicate the picture.

Clinical history and pattern assessment

Purpose: A detailed history of when the itching began, its distribution, seasonal variation, previous treatments and responses, diet, flea control, and the home environment provides crucial diagnostic information. The age of onset, breed predisposition, and characteristic distribution pattern of lesions are among the most diagnostically useful features. Standardised clinical criteria (such as Favrot's criteria) can help assess the likelihood of atopic dermatitis based on clinical features.
Considerations: The history may be complicated by concurrent infections, previous treatments, and the gradual progression of signs. Owners may focus on the most dramatic current symptoms rather than the chronological development of the condition. Seasonal patterns may become less clear as the condition evolves from seasonal to perennial.

Exclusion of ectoparasites

Purpose: Flea allergy dermatitis, sarcoptic mange (scabies), and Demodex infections can produce similar signs to atopic dermatitis and must be excluded before the diagnosis can be made with confidence. This typically involves thorough flea control trials, skin scraping, and sometimes trial treatment for sarcoptic mange. Concurrent flea allergy is common in atopic dogs and can significantly complicate the clinical picture.
Considerations: A negative skin scraping does not completely rule out sarcoptic mange, as the mites can be very difficult to find. A therapeutic trial with an appropriate anti-parasitic treatment may be necessary. Flea control must be comprehensive (treating all in-contact animals and the environment) to be diagnostically meaningful.

Dietary elimination trial

Purpose: A strict elimination diet trial lasting eight to twelve weeks is used to investigate whether food allergy is contributing to the clinical signs. This involves feeding a novel protein or hydrolysed protein diet exclusively, then challenging with the original diet to see if signs return. Cutaneous adverse food reactions can be clinically indistinguishable from environmental atopic dermatitis and may coexist.
Considerations: Compliance with a strict elimination trial is challenging, requiring complete avoidance of all other food sources including treats, flavoured medications, and scavenged items. The trial must be long enough to allow existing inflammation to resolve. Some dogs have both food and environmental allergies, meaning that a partial response to diet change does not exclude environmental triggers.

Allergen-specific testing (intradermal or serology)

Purpose: Once a clinical diagnosis of atopic dermatitis is established, allergen-specific testing can identify the particular environmental allergens to which the dog reacts. Intradermal skin testing involves injecting small amounts of allergen extracts into the skin and observing for reactions. Serology measures allergen-specific IgE levels in the blood. These tests are primarily used to guide allergen-specific immunotherapy rather than to diagnose atopic dermatitis.
Considerations: These tests can produce false positives and false negatives, and results must be interpreted in the context of the clinical picture. They are not diagnostic for atopic dermatitis itself but help identify specific triggers once the diagnosis is established. Intradermal testing requires sedation and a period of medication withdrawal. Serology is more practical but may be less specific.

Options & trade-offs

Management of atopic dermatitis typically involves a multimodal approach combining avoidance strategies, skin barrier support, control of secondary infections, and immunomodulatory or anti-inflammatory therapy. The most effective approach for a given dog usually evolves over time as the individual's trigger profile, seasonal patterns, and treatment responses become clearer.

Skin barrier support and topical therapy

Strengthening the skin barrier through regular bathing with medicated or moisturising shampoos, topical ceramide-containing products, and essential fatty acid supplementation can help reduce allergen penetration and skin water loss. Topical corticosteroid sprays or mousse formulations can provide localised anti-inflammatory relief for problem areas. Regular bathing with appropriate products can physically remove allergens from the skin surface and soothe inflamed tissue.

Trade-offs: Topical therapy requires regular, consistent application which can be time-consuming, particularly for dogs that do not tolerate bathing. The effectiveness of barrier support alone is often insufficient for moderate to severe disease. Topical steroids carry fewer systemic side effects than oral forms but can cause skin thinning with prolonged localised use. Finding the right bathing frequency and products often requires experimentation.

Systemic anti-pruritic medication

Several classes of medication can control itching and inflammation. Oclacitinib (a Janus kinase inhibitor) works rapidly to reduce itch by targeting specific inflammatory pathways. Lokivetmab (a monoclonal antibody against interleukin-31) provides targeted itch relief through monthly injections. Ciclosporin (a calcineurin inhibitor) modulates the immune response more broadly and may take several weeks to reach full effect. Corticosteroids remain effective for short-term flare management but carry significant side effects with long-term use.

Trade-offs: Each medication has a different side effect profile, onset of action, and cost. Oclacitinib acts quickly but requires daily or twice-daily dosing and has potential long-term immunomodulatory effects. Lokivetmab avoids gastrointestinal effects but requires monthly veterinary visits for injection and may lose effectiveness in some dogs over time. Ciclosporin can cause gastrointestinal upset during the initial period. Long-term corticosteroid use carries risks including polyuria, polyphagia, muscle wasting, and iatrogenic Cushing's syndrome.

Allergen-specific immunotherapy

Based on the results of allergen testing, a customised immunotherapy protocol can be developed using subcutaneous injections or sublingual drops containing gradually increasing concentrations of the dog's identified allergens. The goal is to desensitise the immune system and reduce its reactivity over time. This is the only approach that aims to modify the underlying immune dysfunction rather than managing symptoms.

Trade-offs: Immunotherapy requires a commitment of twelve to eighteen months to assess effectiveness, and not all dogs respond favourably. Success rates are typically reported around 60-75% showing meaningful improvement. The treatment involves ongoing administration (injections or sublingual drops) for the long term, often lifelong. Initial allergen testing adds upfront cost, and the immunotherapy itself represents an ongoing expense. Some dogs experience temporary worsening of signs during the dose escalation phase.

Infection management

Treating and preventing secondary bacterial and yeast infections is a critical component of atopic dermatitis management. This may involve systemic antibiotics or antifungals during active infections, topical antimicrobial shampoos and wipes for maintenance, and ear-cleaning protocols for dogs with otitis. Addressing infections often produces a noticeable improvement in comfort, as these secondary invaders significantly amplify itching.

Trade-offs: Recurrent infections are common in atopic dogs, and repeated courses of systemic antibiotics raise concerns about antimicrobial resistance. Culture and sensitivity testing may be needed for resistant infections. Topical antimicrobial maintenance can help reduce reliance on systemic antibiotics but requires consistent application. Balancing infection control with responsible antimicrobial use is an ongoing consideration in chronic atopic patients.

Environmental management

Reducing exposure to known allergens, where feasible, can contribute to overall management. This may include frequent washing of bedding, using air purifiers, wiping paws after walks, limiting exposure during high pollen periods, and managing dust mite exposure through regular cleaning and low-allergen bedding materials. While complete allergen avoidance is rarely possible, reducing the allergen load can lower the threshold for clinical flares.

Trade-offs: Environmental management alone is rarely sufficient to control atopic dermatitis but can meaningfully complement other interventions. The degree to which allergen reduction is practical depends on the specific allergens involved, the dog's lifestyle, and the household circumstances. Measures targeting dust mites require sustained effort, and their effectiveness can be difficult to quantify in an individual patient.

Common misconceptions

Misconception:

"Atopic dermatitis is caused by a food allergy"

Reality:

While food allergy can cause similar skin signs and may coexist with environmental atopic dermatitis, these are distinct conditions with different underlying mechanisms. Atopic dermatitis is primarily a response to environmental allergens such as pollens, dust mites, and moulds. A thorough diagnostic process, including a properly conducted elimination diet trial, is needed to determine whether food plays a role. In many atopic dogs, environmental triggers are the primary drivers, though food sensitivities may contribute in some individuals.

Misconception:

"Itchy skin problems can be cured with the right treatment"

Reality:

Atopic dermatitis is a chronic, genetically influenced condition that can be effectively managed but not cured. The underlying immune predisposition and skin barrier dysfunction persist throughout the dog's life. Management aims to control symptoms, prevent flares, and maintain quality of life. Understanding this chronic nature helps frame realistic expectations and the importance of consistent, long-term management rather than seeking a single curative intervention.

Misconception:

"Frequent bathing is harmful to dogs with skin problems"

Reality:

When performed with appropriate products, regular bathing can be beneficial for dogs with atopic dermatitis. Bathing physically removes allergens from the skin surface, provides soothing relief, helps manage secondary infections, and can deliver topical therapeutic agents directly to the skin. The key is using products designed for canine skin (with an appropriate pH) and moisturising formulations that support rather than deplete the skin barrier. The optimal bathing frequency varies between individuals and may be guided by clinical response.

Understanding atopic dermatitis as a chronic condition with a fluctuating course can help frame expectations about management. Recognising individual triggers, seasonal patterns, and early signs of flares often develops through careful observation over multiple seasons. The approach to management frequently evolves as the dog's specific pattern becomes clearer and responses to different interventions are assessed. Many dogs with atopic dermatitis can be kept comfortable with a well-tailored management plan, though finding the right combination typically requires patience and ongoing adjustment.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS